GPC4 and cancer: Studies show that GPC4 influences various mitogenic signaling pathways including TGF-β [26], TLR4/NF-kB [27], Wnt [22,28,29,30], Mmp14 [31], and FGF2 [32], all of which have the potential to affect cancer progression.